Prothena Corporation plc - Ordinary Shares (PRTA) Social Stream



Prothena Corporation plc - Ordinary Shares (PRTA): $22.78

-0.71 (-3.02%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PRTA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 491

in industry

Featured Post From StockTwits About PRTA

$PRTA not the sexiest chart price wise, but take note of the heavy volume days and see what it's hinting at. I put this stock on my Breakout Watchlist for the week. In the video I cover the setups and buy points for each. Timestamps in the comments: https://youtu.be/lrM07mPI2wc
StockTricksWithNick, published April 4, 2021

Other Notable StockTweets About PRTA


$PRTA The offer price for 3.5 million shares was $20.75--$PRTA should be moving toward or closer into that price range (low $20s). It already started the slide today (down 4.75%). The slide continued in AH (the AH low $26.05). I expect $PRTA to open on Monday in high $25s.

StockTrader0506, published March 26, 2021

$PRTA, a company developing a parkinson's disease drug will be presenting the P2 data of their Prasinezumab (PRX002) at the International Conference on Alzheimer’s and Parkinson’s Diseases on March 11, 2021.

The company got a float of 39.9M shares, of which 90% are held by institution with excellent rating. Only 1.78%of the float is being held short. I was not able to find any S3 filing in EDGAR.

TA: the stock is finding support at a 1STDV below statistical mean on the 1H30D chart. TTM squeeze is indicating that downward momentum has slowed and is entering squeeze mode. We're also at a lower end tail of a volume profile nod.

Risk reward: from the current level, it is safe to say that you can risk $0.8 cents to earn $4.2 per share.

This is a solid 2 days swing. Source:

https://ir.prothena.com/news-releases/news-release-details/prothena-announces-promising-new-preclinical-and-clinical-data

Tain0os, published March 9, 2021

Loading social stream, please wait...



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7007 seconds.